These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38792933)

  • 1. The Impact of COVID-19 Infection on Patients with Severe Chronic Pulmonary Hypertension: A Prospective Study from a Single Referral Center.
    Rudienė V; Kaplerienė L; Laukytė-Slėnienė M; Žebrauskienė D; Averjanovaitė V; Šileikienė V; Zeleckienė I; Matačiūnas M; Gumbienė L; Grigonienė E
    Medicina (Kaunas); 2024 Apr; 60(5):. PubMed ID: 38792933
    [No Abstract]   [Full Text] [Related]  

  • 2. Severity of respiratory failure and computed chest tomography in acute COVID-19 correlates with pulmonary function and respiratory symptoms after infection with SARS-CoV-2: An observational longitudinal study over 12 months.
    Steinbeis F; Thibeault C; Doellinger F; Ring RM; Mittermaier M; Ruwwe-Glösenkamp C; Alius F; Knape P; Meyer HJ; Lippert LJ; Helbig ET; Grund D; Temmesfeld-Wollbrück B; Suttorp N; Sander LE; Kurth F; Penzkofer T; Witzenrath M; Zoller T
    Respir Med; 2022 Jan; 191():106709. PubMed ID: 34871947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary long-term consequences of COVID-19 infections after hospital discharge.
    Blanco JR; Cobos-Ceballos MJ; Navarro F; Sanjoaquin I; Arnaiz de Las Revillas F; Bernal E; Buzon-Martin L; Viribay M; Romero L; Espejo-Perez S; Valencia B; Ibañez D; Ferrer-Pargada D; Malia D; Gutierrez-Herrero FG; Olalla J; Jurado-Gamez B; Ugedo J
    Clin Microbiol Infect; 2021 Jun; 27(6):892-896. PubMed ID: 33662544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic Thromboembolic Pulmonary Hypertension after Pulmonary Embolism in SARS-CoV-2.
    Caguana-Vélez OA; Khilzi K; Piccari L; Rodríguez-Sevilla JJ; Badenes-Bonet D; Gonzalez-Garcia J; Chalela R; Arita M; Rodó-Pin A; Herranz A; Admetlló M; Villar-Garcia J; Molina L; Zuccarino F; Gea J; Balcells E; Rodríguez-Chiaradia DA
    Respiration; 2024; 103(2):79-87. PubMed ID: 38325355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two-year cardio-pulmonary follow-up after severe COVID-19: a prospective study.
    Faverio P; Paciocco G; Tassistro E; Rebora P; Rossi E; Monzani A; Tundo M; Milano C; Messa M; Marocchi R; Pesci A; Foti G; Squillace N; Cogliandro V; Lettino M; Strepparava MG; Bellelli G; Ferrarese C; Valsecchi MG; Bonfanti P; Luppi F;
    Intern Emerg Med; 2024 Jan; 19(1):183-190. PubMed ID: 37715857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 in Patients with Pulmonary Hypertension: A National Prospective Cohort Study.
    Montani D; Certain MC; Weatherald J; Jaïs X; Bulifon S; Noel-Savina E; Nieves A; Renard S; Traclet J; Bouvaist H; Riou M; de Groote P; Moceri P; Bertoletti L; Favrolt N; Guillaumot A; Jutant EM; Beurnier A; Boucly A; Ebstein N; Jevnikar M; Pichon J; Keddache S; Preda M; Roche A; Solinas S; Seferian A; Reynaud-Gaubert M; Cottin V; Savale L; Humbert M; Sitbon O;
    Am J Respir Crit Care Med; 2022 Sep; 206(5):573-583. PubMed ID: 35549842
    [No Abstract]   [Full Text] [Related]  

  • 7. 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study.
    Wu X; Liu X; Zhou Y; Yu H; Li R; Zhan Q; Ni F; Fang S; Lu Y; Ding X; Liu H; Ewing RM; Jones MG; Hu Y; Nie H; Wang Y
    Lancet Respir Med; 2021 Jul; 9(7):747-754. PubMed ID: 33964245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Respiratory and Psychophysical Sequelae Among Patients With COVID-19 Four Months After Hospital Discharge.
    Bellan M; Soddu D; Balbo PE; Baricich A; Zeppegno P; Avanzi GC; Baldon G; Bartolomei G; Battaglia M; Battistini S; Binda V; Borg M; Cantaluppi V; Castello LM; Clivati E; Cisari C; Costanzo M; Croce A; Cuneo D; De Benedittis C; De Vecchi S; Feggi A; Gai M; Gambaro E; Gattoni E; Gramaglia C; Grisafi L; Guerriero C; Hayden E; Jona A; Invernizzi M; Lorenzini L; Loreti L; Martelli M; Marzullo P; Matino E; Panero A; Parachini E; Patrucco F; Patti G; Pirovano A; Prosperini P; Quaglino R; Rigamonti C; Sainaghi PP; Vecchi C; Zecca E; Pirisi M
    JAMA Netw Open; 2021 Jan; 4(1):e2036142. PubMed ID: 33502487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One-year pulmonary impairment after severe COVID-19: a prospective, multicenter follow-up study.
    Faverio P; Luppi F; Rebora P; D'Andrea G; Stainer A; Busnelli S; Catalano M; Modafferi G; Franco G; Monzani A; Galimberti S; Scarpazza P; Oggionni E; Betti M; Oggionni T; De Giacomi F; Bini F; Bodini BD; Parati M; Bilucaglia L; Ceruti P; Modina D; Harari S; Caminati A; Intotero M; Sergio P; Monzillo G; Leati G; Borghesi A; Zompatori M; Corso R; Valsecchi MG; Bellani G; Foti G; Pesci A
    Respir Res; 2022 Mar; 23(1):65. PubMed ID: 35313890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of factors impairing exercise capacity after severe COVID-19 pulmonary infection: a 3-month follow-up of prospective COVulnerability cohort.
    Ribeiro Baptista B; d'Humières T; Schlemmer F; Bendib I; Justeau G; Al-Assaad L; Hachem M; Codiat R; Bardel B; Abou Chakra L; Belmondo T; Audureau E; Hue S; Mekontso-Dessap A; Derumeaux G; Boyer L
    Respir Res; 2022 Mar; 23(1):68. PubMed ID: 35317815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Six-Month Pulmonary Impairment after Severe COVID-19: A Prospective, Multicentre Follow-Up Study.
    Faverio P; Luppi F; Rebora P; Busnelli S; Stainer A; Catalano M; Parachini L; Monzani A; Galimberti S; Bini F; Bodini BD; Betti M; De Giacomi F; Scarpazza P; Oggionni E; Scartabellati A; Bilucaglia L; Ceruti P; Modina D; Harari S; Caminati A; Valsecchi MG; Bellani G; Foti G; Pesci A
    Respiration; 2021; 100(11):1078-1087. PubMed ID: 34515212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
    Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
    Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute pulmonary hypertension and short-term outcomes in severe Covid-19 patients needing intensive care.
    Norderfeldt J; Liliequist A; Frostell C; Adding C; Agvald P; Eriksson M; Lönnqvist PA
    Acta Anaesthesiol Scand; 2021 Jul; 65(6):761-769. PubMed ID: 33728633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary hypertension in chronic lung diseases.
    Seeger W; Adir Y; Barberà JA; Champion H; Coghlan JG; Cottin V; De Marco T; Galiè N; Ghio S; Gibbs S; Martinez FJ; Semigran MJ; Simonneau G; Wells AU; Vachiéry JL
    J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D109-16. PubMed ID: 24355635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of admission viral load on respiratory outcomes in hospitalized SARS-CoV-2 infected patients with cancer and without cancer: A 2-, 4- and 6-months follow-up prospective study.
    Al-Mozaini M; Karim AR; Islam SS
    J Infect Public Health; 2023 Aug; 16(8):1209-1219. PubMed ID: 37276715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffusion Capacity and Mortality in Patients With Pulmonary Hypertension Due to Heart Failure With Preserved Ejection Fraction.
    Hoeper MM; Meyer K; Rademacher J; Fuge J; Welte T; Olsson KM
    JACC Heart Fail; 2016 Jun; 4(6):441-9. PubMed ID: 26874383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated plasma levels of epithelial and endothelial cell markers in COVID-19 survivors with reduced lung diffusing capacity six months after hospital discharge.
    Sibila O; Perea L; Albacar N; Moisés J; Cruz T; Mendoza N; Solarat B; Lledó G; Espinosa G; Barberà JA; Badia JR; Agustí A; Sellarés J; Faner R
    Respir Res; 2022 Feb; 23(1):37. PubMed ID: 35189887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffusing Capacity Is an Independent Predictor of Outcomes in Pulmonary Hypertension Associated With COPD.
    Balasubramanian A; Kolb TM; Damico RL; Hassoun PM; McCormack MC; Mathai SC
    Chest; 2020 Aug; 158(2):722-734. PubMed ID: 32184109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of abnormal pulmonary vasculature on CT scan for COVID-19 infection with decreased diffusion capacity in follow up: A retrospective cohort study.
    Salerno D; Oriaku I; Darnell M; Lanclus M; De Backer J; Lavon B; Gupta R; Jaffe F; Vega Sanchez ME; Kim V;
    PLoS One; 2021; 16(10):e0257892. PubMed ID: 34653196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.